Bessemer Securities LLC Amgen Inc Transaction History

Bessemer Securities LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $796,514 - $911,538	-4,005 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $185,736 - $217,612	-875 Reduced 17.93%	4,005 $852,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $622,457 - $725,373	2,805 Added 135.18%	4,880 $1.21 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $2.34 Million - $2.88 Million	-11,847 Reduced 85.1%	2,075 $489,000
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $208,131 - $267,520	-1,100 Reduced 7.32%	13,922 $3.36 Million

Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $34,822 - $41,724	-200 Reduced 1.31%	15,022 $2.91 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $116,689 - $136,787	700 Added 4.82%	15,222 $2.81 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $4,340 - $4,893	-24 Reduced 0.16%	14,522 $2.76 Million
Q4 2018 May 21, 2019	BUY	$178.4 - $208.25 $2.6 Million - $3.03 Million	14,546 New	14,546 $2.83 Million

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bessemer Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Bessemer Securities LLC with notifications on news.